[144] Semtech Corp SEC Filing

Rhea-AI Filing Summary

FormFactor Inc. (FORM) has filed a Form 144 notice indicating an intended insider sale of up to 4,000 common shares through Morgan Stanley Smith Barney on or about 01 Jul 2025. Based on the filing’s stated aggregate market value of $136,106.80, the planned transaction represents roughly 0.005 % of the company’s 77,076,642 shares outstanding, implying minimal ownership dilution or trading-volume impact.

The seller, identified in the past-sales table as Mike Slessor, acquired the shares as performance stock on 19 Jul 2022. The document notes no gift status or non-cash consideration. Within the preceding three months, the same individual sold 8,000 shares in two tranches (01 May 2025 and 02 Jun 2025) for combined gross proceeds of $246,188.80. Adding the upcoming sale would bring the rolling three-month total to 12,000 shares.

The filing contains the standard representation that the seller is not in possession of undisclosed material adverse information and provides no indication of additional planned transactions beyond the stated amount. Given the modest size relative to market float and the routine nature of a Rule 144 filing, immediate financial impact appears limited; however, continued insider selling can sometimes influence investor sentiment.

Positive

• Regulatory compliance: Timely Form 144 filing demonstrates transparency and adherence to SEC insider-sale rules.

Negative

• Continued insider selling: Aggregate 12,000 shares sold or planned within three months could be perceived as waning insider confidence, despite small relative size.

Insights

Securities Analyst

TL;DR: Small insider sale (0.005 % float) is routine; sentiment risk minor, fundamental impact negligible.

The filing covers 4,000 shares worth about $136k, following two earlier 4,000-share tranches. Even aggregated, 12,000 shares equal only ~0.016 % of outstanding stock, so supply overhang is immaterial. Because the shares derive from performance awards, the sale may simply reflect personal diversification rather than adverse views on FormFactor’s outlook. No pricing details beyond market value are disclosed, and nothing in the notice suggests undisclosed operational issues. From a valuation standpoint, therefore, I see neutral financial impact; the primary takeaway is a potential marginal sentiment headwind if investors focus on the insider activity.

Corporate Governance Specialist

TL;DR: Filing signals compliance and transparency; repeated sales could draw light governance scrutiny.

Rule 144 notices are expected when insiders dispose of restricted stock. The prompt disclosure underscores adherence to SEC requirements, which is governance-positive. Nonetheless, three sales within three months may trigger investor questions about executive alignment, especially absent offsetting insider purchases. The percentage sold is immaterial to control, so no governance red flags arise. Overall, the event is non-impactful but worth monitoring if sales accelerate.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	999	44395.56	86635593	07/01/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2025	Stock Award	Issuer			999	07/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Lin c/o 200 FLYNN ROAD Camarillo CA 93012	Common	04/01/2025	1013	34890.25
Mark Lin c/o 200 FLYNN ROAD Camarillo CA 93012	Common	06/05/2025	3774	143256.51

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many FormFactor (FORM) shares are covered by the new Form 144 filing?

The notice covers 4,000 common shares.

What is the approximate market value of the shares to be sold?

The aggregate market value stated is $136,106.80.

When is the planned sale date for the Form 144 shares?

The filer lists an approximate sale date of 01 July 2025.

What percentage of FormFactor’s outstanding shares does 4,000 shares represent?

Roughly 0.005 % of the 77,076,642 shares outstanding.

What insider sales occurred in the prior three months?

The same seller disposed of 8,000 shares in May and June 2025 for total proceeds of $246,188.80.

Who is the broker executing the proposed transaction?

The broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York.